
Paul Bertone, PhD
Core Director (Single Cell Technologies); TRDG Member, Bioinfomatics Single cell profiling

Benedito Carneiro, MD
Group Leader (Cancer Therapeutics); TRDG Leader (GU Cancer); Director, Phase I Clinical Research Program, Cell death targeted therapeutics, Immunotherapy

Tom DiPetrillo, MD
TRDG Leader (Thoracic Malignancies and GU Cancer); Radiation Oncology, IMRT, HDR, Brachytherapy

Wafik El-Deiry, MD, PhD, FACP
Director, Joint Program in Cancer Biology; TRDG Leader and Facilitator, Drug Discovery, Signaling, drug resistance, TRAIL, p53, p21, ONC201

Liz Hernandez Borrero, PhD candidate
Translational theraputics

Sheldon Holder, MD, PhD
Assistant Professor of Pathology and Laboratory Medicine | Medical Oncologist | Physician Scientist

Aakash Jhaveri, MS candidate
Translational Therapeutics

Ohad Kott, MD
GU Oncology

Chanika Phornphutkul, MD
Chief of the Division of Human Genetics and Director of Genetics and Metabolism Clinic at Rhode Island/Hasbro Children's Hospital

Howard Safran, MD
Group Leader (Cancer Therapeutics); TRDG Leader and Facilitator, Medical Director, BrUOG, Chief, Hematology/Oncology, Brown and Lifespan, GI and brain cancer therapeutics, Experimental therapeutics

Neil Sarkar, PhD
Group Leader (Population Science); Biomedical Informatics, Health Services and Policy

Attila A Seyhan, PhD
Director of Translational Oncology Operations, Joint Program in Cancer Biology, Brown University and Lifespan Cancer Institute; Core Director of Translational Oncology; Adjunct Associate Professor, Tumor metabolism and RNA processing

Xiaobing Tian, PhD
Core Director (Organic Synthesis); Research Assistant Professor, Integrated stress response, Cell signaling, Myc, Puma, p53

Shengliang Zhang, MD, PhD
Core Director (Drug Discovery); Research Assistant Professor, ROS, ERK2, MDM2, p53

Yiqun Zhang, PhD
Translational Therapeutics

Shuai Zhao, PhD candidate
Translational Therapeutics